Clinical trial · Interventional
Bright White Light Therapy for the Improvement of Sleep, Fatigue, Distress, Depression, and Anxiety in Hospitalized Leukemia Patients
The Effects of Bright White Light Therapy on Fatigue, Sleep, Distress, Depression and Anxiety in the Hospitalized Leukemia Patient
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This trial investigates how well bright white light therapy works in improving sleep, fatigue, distress, depression, and anxiety, side effects that are often experienced during an intense leukemia treatment regimen, in hospitalized leukemia patients. Bright white light therapy may help to control these symptoms, and information from this study may help doctors and nurses learn more about methods for decreasing these symptoms.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Leukemia | Acute Leukemia | ONTOLOGY_EXACT | 0.90 |
| Recurrent Leukemia | Leukemia | CURATED_BROADER | 0.78 |
| Refractory Leukemia | Leukemia | CURATED_BROADER | 0.78 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Best Practice | Other | — | UNRESOLVED |
| Bright White Light Therapy | Procedure | — | UNRESOLVED |
| Survey Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group I (BWLT, best practice)
- description
- Patients receive BWLT over 30 minutes in addition to standard of care daily during hospital stay.
- interventionNames
- Other: Best Practice
- Procedure: Bright White Light Therapy
- Other: Survey Administration
- type
- ACTIVE_COMPARATOR
- label
- Group II (standard of care)
- description
- Patients receive standard of care during hospital stay.
- interventionNames
- Other: Best Practice
- Other: Survey Administration
Primary outcomes (1)
- measure
- Level of fatigue
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Admitted to the Acute Leukemia Unit for an anticipated stay of 3 weeks or longer * English speaking * Able to comprehend and sign a consent form * Able to read and complete surveys * Alert and oriented * Without BWLT for seven days prior to initiating the trial Exclusion Criteria: * Current eye disorders which is defined as: * Iritis, uveitis, keratitis, cataract, glaucoma, macular degeneration, retinal detachment, or retinitis pigmentosa * Diagnosed bipolar disorder * Persons with pacemakers * The manufacturer of the BWLT unit used for this study mentions the light unit contains magnets
References
Publications (0)
Data not yet available